vs

Side-by-side financial comparison of Eastman Chemical Company (EMN) and Genpact LTD (G). Click either name above to swap in a different company.

Eastman Chemical Company is the larger business by last-quarter revenue ($2.0B vs $1.3B, roughly 1.5× Genpact LTD). Genpact LTD runs the higher net margin — 10.8% vs 5.3%, a 5.5% gap on every dollar of revenue. On growth, Genpact LTD posted the faster year-over-year revenue change (5.6% vs -13.8%). Over the past eight quarters, Genpact LTD's revenue compounded faster (8.0% CAGR vs -8.6%).

Eastman Chemical Company is an American chemical products manufacturer based in Kingsport, Tennessee. Founded in 1920, it was formerly a subsidiary of Kodak until 1994. The company is an independent global specialty materials company that produces a broad range of advanced materials, chemicals and fibers for everyday purposes. It operates 36 manufacturing sites worldwide and employs approximately 14,000 people. In 2023, Eastman had sales revenue of approximately $9.21 billion.

Genpact Ltd. is an American information technology services, consulting, and outsourcing company headquartered in New York City, New York. Founded in Gurgaon, India, and legally domiciled in Bermuda, Genpact employs more than 125,000 people and provides services to clients in over 30 countries worldwide. Genpact is listed on the NYSE and generated revenues of US$4.48 billion in 2023.

EMN vs G — Head-to-Head

Bigger by revenue
EMN
EMN
1.5× larger
EMN
$2.0B
$1.3B
G
Growing faster (revenue YoY)
G
G
+19.5% gap
G
5.6%
-13.8%
EMN
Higher net margin
G
G
5.5% more per $
G
10.8%
5.3%
EMN
Faster 2-yr revenue CAGR
G
G
Annualised
G
8.0%
-8.6%
EMN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
EMN
EMN
G
G
Revenue
$2.0B
$1.3B
Net Profit
$105.0M
$143.1M
Gross Margin
17.1%
36.6%
Operating Margin
14.8%
Net Margin
5.3%
10.8%
Revenue YoY
-13.8%
5.6%
Net Profit YoY
-42.3%
0.8%
EPS (diluted)
$0.93
$0.82

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EMN
EMN
G
G
Q1 26
$2.0B
Q4 25
$2.0B
$1.3B
Q3 25
$2.2B
$1.3B
Q2 25
$2.3B
$1.3B
Q1 25
$2.3B
$1.2B
Q4 24
$2.2B
$1.2B
Q3 24
$2.5B
$1.2B
Q2 24
$2.4B
$1.2B
Net Profit
EMN
EMN
G
G
Q1 26
$105.0M
Q4 25
$105.0M
$143.1M
Q3 25
$47.0M
$145.8M
Q2 25
$140.0M
$132.7M
Q1 25
$182.0M
$130.9M
Q4 24
$330.0M
$141.9M
Q3 24
$180.0M
$132.8M
Q2 24
$230.0M
$122.0M
Gross Margin
EMN
EMN
G
G
Q1 26
17.1%
Q4 25
17.1%
36.6%
Q3 25
19.7%
36.4%
Q2 25
22.1%
35.9%
Q1 25
24.8%
35.3%
Q4 24
24.7%
35.7%
Q3 24
24.6%
35.6%
Q2 24
25.3%
35.4%
Operating Margin
EMN
EMN
G
G
Q1 26
Q4 25
0.6%
14.8%
Q3 25
6.1%
14.8%
Q2 25
7.4%
14.3%
Q1 25
11.0%
15.1%
Q4 24
13.2%
15.2%
Q3 24
11.4%
15.0%
Q2 24
12.1%
14.5%
Net Margin
EMN
EMN
G
G
Q1 26
5.3%
Q4 25
5.3%
10.8%
Q3 25
2.1%
11.3%
Q2 25
6.1%
10.6%
Q1 25
7.9%
10.8%
Q4 24
14.7%
11.4%
Q3 24
7.3%
11.0%
Q2 24
9.7%
10.4%
EPS (diluted)
EMN
EMN
G
G
Q1 26
$0.93
Q4 25
$0.93
$0.82
Q3 25
$0.40
$0.83
Q2 25
$1.20
$0.75
Q1 25
$1.57
$0.73
Q4 24
$2.81
$0.80
Q3 24
$1.53
$0.74
Q2 24
$1.94
$0.67

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EMN
EMN
G
G
Cash + ST InvestmentsLiquidity on hand
$566.0M
$1.2B
Total DebtLower is stronger
$1.5B
Stockholders' EquityBook value
$6.0B
$2.5B
Total Assets
$14.9B
$5.8B
Debt / EquityLower = less leverage
0.60×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EMN
EMN
G
G
Q1 26
$566.0M
Q4 25
$566.0M
$1.2B
Q3 25
$740.8M
Q2 25
$663.3M
Q1 25
$561.6M
Q4 24
$837.0M
$671.6M
Q3 24
$1.0B
Q2 24
$914.2M
Total Debt
EMN
EMN
G
G
Q1 26
Q4 25
$1.5B
Q3 25
$1.2B
Q2 25
$1.2B
Q1 25
$1.2B
Q4 24
$1.2B
Q3 24
$1.6B
Q2 24
$1.6B
Stockholders' Equity
EMN
EMN
G
G
Q1 26
$6.0B
Q4 25
$6.0B
$2.5B
Q3 25
$5.8B
$2.5B
Q2 25
$5.8B
$2.6B
Q1 25
$5.9B
$2.5B
Q4 24
$5.8B
$2.4B
Q3 24
$5.7B
$2.4B
Q2 24
$5.6B
$2.3B
Total Assets
EMN
EMN
G
G
Q1 26
$14.9B
Q4 25
$14.9B
$5.8B
Q3 25
$15.0B
$5.4B
Q2 25
$15.2B
$5.3B
Q1 25
$15.0B
$4.9B
Q4 24
$15.2B
$5.0B
Q3 24
$15.1B
$5.3B
Q2 24
$14.9B
$5.2B
Debt / Equity
EMN
EMN
G
G
Q1 26
Q4 25
0.60×
Q3 25
0.47×
Q2 25
0.47×
Q1 25
0.50×
Q4 24
0.51×
Q3 24
0.68×
Q2 24
0.70×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EMN
EMN
G
G
Operating Cash FlowLast quarter
$286.7M
Free Cash FlowOCF − Capex
$269.0M
FCF MarginFCF / Revenue
20.4%
Capex IntensityCapex / Revenue
1.3%
Cash ConversionOCF / Net Profit
2.00×
TTM Free Cash FlowTrailing 4 quarters
$734.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EMN
EMN
G
G
Q1 26
Q4 25
$502.0M
$286.7M
Q3 25
$402.0M
$308.4M
Q2 25
$233.0M
$177.4M
Q1 25
$-167.0M
$40.4M
Q4 24
$540.0M
$203.2M
Q3 24
$396.0M
$228.5M
Q2 24
$367.0M
$209.3M
Free Cash Flow
EMN
EMN
G
G
Q1 26
Q4 25
$390.0M
$269.0M
Q3 25
$265.0M
$292.0M
Q2 25
$83.0M
$155.1M
Q1 25
$-314.0M
$18.5M
Q4 24
$361.0M
$183.5M
Q3 24
$276.0M
$208.7M
Q2 24
$252.0M
$190.0M
FCF Margin
EMN
EMN
G
G
Q1 26
Q4 25
19.8%
20.4%
Q3 25
12.0%
22.6%
Q2 25
3.6%
12.4%
Q1 25
-13.7%
1.5%
Q4 24
16.1%
14.7%
Q3 24
11.2%
17.2%
Q2 24
10.7%
16.2%
Capex Intensity
EMN
EMN
G
G
Q1 26
Q4 25
5.7%
1.3%
Q3 25
6.2%
1.3%
Q2 25
6.6%
1.8%
Q1 25
6.4%
1.8%
Q4 24
8.0%
1.6%
Q3 24
4.9%
1.6%
Q2 24
4.9%
1.6%
Cash Conversion
EMN
EMN
G
G
Q1 26
Q4 25
4.78×
2.00×
Q3 25
8.55×
2.11×
Q2 25
1.66×
1.34×
Q1 25
-0.92×
0.31×
Q4 24
1.64×
1.43×
Q3 24
2.20×
1.72×
Q2 24
1.60×
1.72×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EMN
EMN

Segment breakdown not available.

G
G

High Tech And Manufacturing$525.3M40%
Consumer And Healthcare$445.8M34%
Financial Services$348.2M26%

Related Comparisons